Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 4Boehringer lngelheim Animal Health Canada Inc.

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
American Pharma Summit
Not Confirmed
arrow
American Pharma Summit
Not Confirmed

Afoxolaner

Brand Name : NEXGARD

Patent Number : 2632694

Filing Date : 2006-12-28

Strength per Unit : 11.3 mg

Dosage Form : TABLET (CHEWABLE)

Human Or VET : Veterinary

Route of Administration : ORAL

Patent Expiration Date : 2026-12-28

Date Granted : 2014-10-28

blank

02

arrow
American Pharma Summit
Not Confirmed
arrow
American Pharma Summit
Not Confirmed

Afoxolaner

Brand Name : NEXGARD

Patent Number : 2632694

Filing Date : 2006-12-28

Strength per Unit : 28.3 mg

Dosage Form : TABLET (CHEWABLE)

Human Or VET : Veterinary

Route of Administration : ORAL

Patent Expiration Date : 2026-12-28

Date Granted : 2014-10-28

blank

03

arrow
American Pharma Summit
Not Confirmed
arrow
American Pharma Summit
Not Confirmed

Afoxolaner

Brand Name : NEXGARD

Patent Number : 2632694

Filing Date : 2006-12-28

Strength per Unit : 68.0 mg

Dosage Form : TABLET (CHEWABLE)

Human Or VET : Veterinary

Route of Administration : ORAL

Patent Expiration Date : 2026-12-28

Date Granted : 2014-10-28

blank

04

arrow
American Pharma Summit
Not Confirmed
arrow
American Pharma Summit
Not Confirmed

Afoxolaner

Brand Name : NEXGARD

Patent Number : 2632694

Filing Date : 2006-12-28

Strength per Unit : 136.0 mg

Dosage Form : TABLET (CHEWABLE)

Human Or VET : Veterinary

Route of Administration : ORAL

Patent Expiration Date : 2026-12-28

Date Granted : 2014-10-28

blank